AZ withdraws Brilinta batch for containing the wrong drug after packaging mix-up
June 6, 2017Manufacturing and Production AstraZeneca
The United Arab Emirates Ministry of Health and Prevention has called for the withdrawal of a batch of AstraZeneca’s cardiovascular …
Novel Drug Movers and Shakers 2013-2016
June 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
To view the original whitepaper from NDA, please click here.Small and Medium Sized Companies in North America Lead Novel Drug …
Recipharm opens new GMP suite for clinical trial material
June 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) …
New game, new rules: Pathways for better and affordable medicines in Europe
June 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, market access
Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), discusses the latest …
BMS’ Opdivo scores eighth approval in Europe for bladder cancer
June 5, 2017Research and Development, Sales and Marketing Bristol-Myers Squibb, Cancer, Europe, European Commission, bladder cancer, immunotherapy
Bristol-Myers Squibb has announced that its flagship immunotherapy treatment Opdivo (nivolumab) has secured its eighth approval in Europe as the …
Merck KGaA signs potential $1 billion deal with UK biotech
June 5, 2017Sales and Marketing F-star, Merck KGaA
UK biotech, F-Star, has scored a boost to its coffers with another link-up with a big pharma company, this time …
Latest prostate cancer research could provide boost for J&J
June 5, 2017Research and Development, Sales and Marketing CRUK, Cancer, Johnson & Johnson, prostate cancer
Research funded by Cancer Research UK has found that abiraterone added to hormone therapy improved survival by over a third …
New targeted therapy promises strong response rate across 17 cancer types
June 5, 2017Research and Development, Sales and Marketing ASCO, Cancer, Loxo Oncology, oncology
Loxo Oncology’s lead therapy larotrectinib made a big impact at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, …
Breakthrough treatment for ovarian cancer displays promising results
June 5, 2017Research and Development, Sales and Marketing Amgen, Cancer, ICR, ovarian cancer
A treatment that specifically targets ovarian cancer cells has shown that half of women who took the drug experienced shrinking …
Tau pathology as the key to understanding Alzheimer’s disease
June 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common type of dementia (60–70%)[1], causing problems with memory, language, …
Abbvie names new General Managers for UK and France
June 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, appointment
Abbvie has announced a double appointment across its UK and French operations, naming Jérôme Bouyer as its UK General Manager, …
Research provides clues about Zika virus damage to foetal brains
June 2, 2017Research and Development India, Zika, Zika virus
The Zika virus has been documented since 1947 and was first discovered to have infected a human in 1952. The …
ABPI appoints new Executive Director of Government Affairs
June 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI
The ABPI has moved to appoint Saratha Rajeswaran to the position of Executive Director of Government Affairs and Devolved Nations. …
AZ’s Lynparza improves survival and maintains quality of life against ovarian cancer
June 2, 2017Medical Communications, Research and Development AstraZeneca, lynparza
New Phase 3 trial data has found that AstraZeneca’s Lynparza (olaparib) provides sustained quality of life (QoL) and improved progression-free …
Old antibiotic offers potential cost-effective MS treatment
June 2, 2017Medical Communications, Research and Development Myelin, multiple sclerosis
The cost of treatment for multiple sclerosis varies wildly, in the UK treatment can cost £56,000 per year while in …
Top Ten most popular articles on Pharmafile.com this week
June 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s Friday again, and the past week was populated with a host of riveting news and features from the life …
NICE U-turns to recommend Sanofi Gaucher disease drug
June 2, 2017Medical Communications, Sales and Marketing Gaucher disease, NICE, Sanofi
It has been revealed that NICE has reached the decision to recommend Sanofi’s Cerdelga (eligustat) for use on the NHS …
Childhood mortality from diarrhoea falls by third
June 2, 2017Medical Communications Diarhhoea, India, Nigeria
A study has found that the rates of children dying from diarrhoea worldwide fell by a third through the decade …
Clinical Trial Success: How Relationships Are Key
June 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing contract research organisations, cros
Jeffrey Zucker, Vice President of Feasibility and Recruitment Optimisation at Worldwide Clinical Trials, offers strategies for establishing and maintaining key …
Silence Therapeutics instate new COO
June 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Silence Therapeutics
Silence Therapeutics, a company focused on developing medicines through the body’s natural mechanism of RNA interference, has appointed a new …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
